Blackstone Life Sciences V L.P. — Form D/A
Blackstone Life Sciences V L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2020-05-13. The offering totals $4.6B, of which $4.2B was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-05-13
- Form: D/A
- Accession: 0001797712-20-000003
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $4.6B
- Amount sold: $4.2B
- Remaining: $377.6M
- Investors: 99
- Date of first sale: 2019-12-31
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-357589
Issuer
- Name: Blackstone Life Sciences V L.P.
- CIK: 0001797712
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 345 PARK AVENUE, NEW YORK, NY, 10154
- Phone: 212-583-5000
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Matthew G Skurbe | Executive Officer | New York, NY |
| Christopher G Placca | Executive Officer | New York, NY |
| Robert G Liptak | Executive Officer | New York, NY |
| Joseph NA Baratta | Executive Officer | New York, NY |
| n/a na BXLS V L.L.C. | Promoter | New York, NY |
| Christopher G Striano | Executive Officer | New York, NY |
| Omar G Rehman | Executive Officer | New York, NY |
| John G Finley | Executive Officer | New York, NY |
| N/A NA Blackstone Life Sciences Associates V L.P. | Promoter | New York, NY |
| Nick G Galakatos | Executive Officer | New York, NY |
Other filings by this issuer (3)
More